BioSim™ Cetuximab (Human) ELISA Kit

Cetuximab is a chimeric monoclonal antibody of the immunoglobulin G1 (IgG1) and FDA-approved epidermal growth factor receptor (EGFR) inhibitor. Preclinical studies have shown that cetuximab enhances the antitumour effects of chemotherapy as well as radiotherapy by inhibiting cell proliferation, angiogenesis and metastasis and by promoting apoptosis is used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab blocks growth factor-induced activation of the downstream mitogen-activated protein kinase, inhibiting cell proliferation. It also decreases angiogenic factors, inhibits tumor-cell invasion and metastasis via downregulation of matrix metalloproteinases (MMPs) and VEGF, and promotes apoptosis by upregulating apoptotic protein, Bax, with the help of other chemotherapeutic agents. BioSim™ Cetuximab ELISA kit has been developed for specific quantification of Cetuximab concentration in human serum or plasma with high sensitivity and reproducibility.

Alternate Name: ERBB, HER1, mENA, ERBB1, PIG61, NISBD2, EGFR, CAS 205923-56-4

Tag Line: A Sandwich ELISA kit for the quantitative measurement of free Cetuximab in human serum or plasma.

Summary: N/A

Detection Method: Absorbance (450 nm)

Sample Type: Human serum and plasma

Species Reactivity: Human

Applications: This ELISA kit is used for quantitative measurement of Cetuximab in human serum and plasma

Features & Benefits: • Easy, convenient, sensitive and time-saving method to measure the level of Cetuximab in human serum and plasma. • Detection Range: 100 - 3000 ng/ml • Sensitivity: 100 ng/ml • Assay Precision: Intra-Assay: CV < 15%; Inter-Assay: CV < 15% (CV (%) = SD/mean X 100) • Recovery rate: 85 – 115% with normal human serum samples with known concentrations • Cross Reactivity: There is no cross reaction with native serum immunoglobulins